Tag: NASDAQ: GENE

Business

Genetic Technologies Limited (NASDAQ: GENE) Gains 9% Following Award of Pharmacogenomic Patent

Genetic Technologies Limited (NASDAQ: GENE) jumped 9.13% after the company received a US Patent No. 11,031,098 – ‘Computer Systems and Methods for Genomic Analysis.’ The patent builds on a previously issued patent. The genomics and AI-driven preventive health company had filed the patent application in 2016, expanding on a patent […]